Companies: 10,795·Total market cap: $144.5T

Orgenesis Inc.

Orgenesis Inc.

ORGSOTCHealthcare● Active

$0.50

+$0.01(+1.02%)

Market Cap$2558779

P/E Ratio—

52W High$5.89

52W Low$0.02

Avg Volume2K

Open$0.50

Beta2.97

Orgenesis Inc. (ORGS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ORGS · net income · updated Jun 9, 2026

Core profitability metrics

ORGS · net income · margin · TTM · CAGR

Net income was −$55.4M for FY2023 (fiscal year ending 2023-12-31), down 271.8% year-over-year. Net profit margin was -10445.5%.

FY2023 Net Income−$55.4M▼ -271.8% YoY

Trailing 12M (TTM)−$43.9Mtrailing 4 quarters sum

Net Profit Margin< −999%−$55.4M ÷ $530,000

YoY Change-271.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · ORGS net income history · ORGS profit margin

Annual net income data

ORGS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2023Loss−$55.4M▼ 271.8%-10445.5%$530,000

FY2022Loss−$14.9M▲ +17.6%-41.3%$36.0M

FY2021Loss−$18.1M▲ +81.2%-50.9%$35.5M

FY2020Loss−$95.8M▼ 267.9%-1252.1%$7.7M

FY2019Loss−$26.0M▼ 42.4%-78.3%$33.3M

Net income vs peers (Healthcare)

ORGS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Orgenesis Inc.YOU

ORGS

−$55.4M-271.8%-10445.5%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Orgenesis Inc. (ORGS) reported net income of −$55.4M for FY2023 (fiscal year ending 2023-12-31), down 271.8% year-over-year. The net profit margin was -10445.5% — meaning the company kept $-104.45 of every dollar of revenue as profit.

Orgenesis Inc. has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.

Orgenesis Inc.'s net profit margin was -10445.5% for FY2023, based on the latest annual results.

Investors sometimes search for "Orgenesis Inc. net worth" — the company's market capitalization is a separate figure from ORGS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ORGS net income · 4 questions

Orgenesis Inc. is not currently profitable on an annual basis. The company reported a net loss of $55.4M for FY2023.

is ORGS profitabledoes ORGS make a profitORGS profitabilityORGS profitable company

▸ Source: FMP /income-statement · GAAP · Orgenesis Inc. · Orgenesis Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026